Small Molecules in FDA’s New Drug Approvals 2025: Implications for 2026 Drug Development
Small molecules still dominate FDA approvals, but rising stereochemical and solid-state complexity demands stronger CMC strategies for 2026 readiness.
The Process Development Blog
Cutting edge process development insights and news from APC.
-
Read More
-
A HTE + PAT Strategy for Accelerated Bio-process Development
Read MoreA lack of process understanding & control leads to: inability to scale, product quality drift, & costly delays from batch failures & regulatory concerns
-
Explore By
Related Services
Power Up Your Process Development Knowledge
Receive actionable process development insights and explore cutting edge process development news with great science delivered to your inbox every couple of months.